Print

Series A financing round of Aleva Neurotherapeutics SA

25.08.2011
Aleva Neurotherapeutics SA closes EUR 9.5 Mio. (CHF 10.1 Mio.) Series A financing round with BioMedInvest II LP as co-lead investor.

Aleva Neurotherapeutics Series A_FINAL.pdf
59 kB

© BioMedPartners 2007top